Obesity, insulin resistance, and colorectal cancer: Could miRNA dysregulation play a role?

66Citations
Citations of this article
95Readers
Mendeley users who have this article in their library.

Abstract

Obesity is associated with insulin resistance and low-grade inflammation. Insulin resistance is a risk factor for cancer. A recent chapter in epigenetics is represented by microRNAs (miRNAs), which post-transcriptionally regulate gene expression. Dysregulated miRNA profiles have been associated with diseases including obesity and cancer. Herein we report dysregulated miRNAs in obesity both in animal models and in humans, and we also document dysregulated miRNAs in colorectal cancer (CRC), as example of an obesity-related cancer. Some of the described miRNAs are found to be similarly dysregulated both in obesity, insulin resistance (IR), and CRC. Thus, we present miRNAs as a potential molecular link between obesity and CRC onset and development, giving a new perspective on the role of miRNAs in obesity-associated cancers.

Cite

CITATION STYLE

APA

Cirillo, F., Catellani, C., Sartori, C., Lazzeroni, P., Amarri, S., & Street, M. E. (2019, June 2). Obesity, insulin resistance, and colorectal cancer: Could miRNA dysregulation play a role? International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms20122922

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free